Ursodeoxycholic acid (UDCA) suppresses liver interleukin 2 mRNA in the cholangitis model

Hepato-Gastroenterology

Volumn 52, Issue 62, 2005, Pages 596-602

  Miyaguchi, Shingo ^a   Mori, Masaya ^b  

^a Harunaso Hospital   (Japan)

^b TORANOMON HOSPITAL   (Japan)

Author keywords

Cholangitis model; Cytokines; Primary biliary cirrhosis

Indexed keywords

CARBONATE DEHYDRATASE II; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 6; MESSENGER RNA; URSODEOXYCHOLIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INVASION; CHOLANGITIS; CONTROLLED STUDY; DISEASE MODEL; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; FEMALE; HISTOPATHOLOGY; LIVER LEVEL; MOUSE; MOUSE STRAIN; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ASSAY;

ALKALINE PHOSPHATASE; ANIMALS; CARBONIC ANHYDRASE II; CHOLANGITIS; CYTOKINES; FEMALE; IMMUNIZATION; INTERLEUKIN-2; LEUCYL AMINOPEPTIDASE; LIVER; MICE; MICE, INBRED BALB C; RNA, MESSENGER; TRANSAMINASES; URSODEOXYCHOLIC ACID;

EID: 16344395679     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Kaplan MM: Primary biliary cirrhosis. New Eng J Med 1996; 335:1570-1580.
2. Heathcote EJ: Management of primary biliary cirrhosis. The American Association for the study of liver diseases practice guidelines. Hepatology 1998; 31:1005-1013.
3. Tanaka H, Makino Y, Miura T, Hirano F, Okamoto K, Komura K, Sato Y, Makino I: Ligand-independent activation of the glucocorticoid receptor by ursodeoxycholic acid. Repression of IFN-gamma-induced MHC class II gene expression via a glucocorticoid receptor-dependent pathway. J Immunol 1996; 15:1601-1608.
4. Yoshikawa M, Tsuji T, Matsumura K, Yamao J, Matsumura Y, Kubo R, Fukui H, Ishizawa S: Immunomodulatory effects of ursodeoxycholic acid on immune response. Hepatology 1992; 16:358-364.
5. Abedi MR, Hammarstrom L, Broome U, Angelin B, Smith CI, Christensson B: Reduction in serum levels of antimitochondrial (M2) antibodies following immunoglobulin therapy in severe combined immunodeficient (SCID) mice reconstituted with lymphocytes from patients with primary biliary cirrhosis (PBC). Clin Exp Immunol 1996; 105:266-273.
6. Krams SM, Surh CD, Coppel RL, Ansari A, Ruebner B, Gershwmi ME: Immunization of experimental animals with dihydrolipoamide acetyltransferase as a purified recombinant polypeptide generates mitochondrial antibodies but not primary biliary cirrhosis. Hepatology 1989; 9:411-416.
7. Epstein O, Thomas HC, Sherlock S: Primary biliary cirrhosis is a dry gland syndrome with features of chronic graft-versus-host disease. Lancet 1980; 31:1166-1168.
8. Ueno Y, Ishii M, Takahashi S, Igarashi T, Toyota T, LaRusso NF: Different susceptibility of mice to immune-mediated cholangitis induced by immunization with carbonic anhydrase II. Lab Invest 1998; 78:629-637.
9. Itoh S, Matsuzaki Y, Kimura T, Tkegami T, Shoda J, Fujiwara M, Tanaka N: Cytokine profile of liver-infiltrating CD4+ T cells separated from murine primary biliary cirrhosis-like hepatic lesions induced by graft-versus-host reaction. J Gastroenterol Hepatol 2000; 15:443-451.
10. Street NE, Mosmann TR: Functional diversity of T lymphocytes due to secretion of different cytokine patterns. FASEB J 1991; 5:171-177.
11. Mosmann TR: The expanding universe of T-cell subsets: Th1, Th2 and more [see comments]. Immunol Today 1996; 17:138-146.
12. Mosmann TR, Coffman RL: TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989; 7:145-173.
13. Miller LC, Kaplan MM: Serum interleukin-2 and tumor necrosis factor-alfa in primary biliary cirrhosis: decrease by colchicine and relationship to HLA-DR4. Am J Gastroenterol 1992; 87:465-470.
14. Tilg H, Wilmer A, Vogel W, Herold M, Nolchen B, Judmaier G, et al: Serum levels of cytokines in chronic liver diseases. Gastroenterology 1992; 103:264-274.
15. Löhr HF, Schlaak JF, Gerken G, Fleischer B, Dienes HP, Meyer zum Buschenfelde KH: Phenotypical analysis and cytokine release of liver-infiltrating and peripheral blood T lymphocytes from patients with chronic hepatitis of different etiology. Liver 1994; 14:161-166.
16. Harada K, Water JV, Leung PSC, Coppel RL, Ansari A, Nakanuma Y, Gershwin ME: In situ nucleic acid hybridization of cytokines in primary biliary cirrhosis: predominance of the Th2 subset. Hepatology 1997; 25:791-796.
17. Yamada G, Hyodo I, Tobe K, Mizuno M, Nishihara T, Kobayashi T, Nagashima H: Ultrastructural immunocytochemical analysis of lymphocytes infiltrating bile duct epithelia in primary biliary cirrhosis. Hepatology 1986; 6:385-391.
18. Toru H, Ra C, Nonoyama S, Suzuki K, Yata J, Nakahata T: Induction of the high-affinity IgE receptor (Fe epsilon RI) on human mast cells by IL-4. Int Immunol 1996; 8:1367-1373.
19. Moser R, Groscurth P, Carballido JM, Bruijinzeel PB, Blaser K, Heusser CH, et al: Interleukin-4 induces tissue eosinophilia in mice: correlation with its in vitro capacity to stimulate the endothelial cell-dependent selective transmigration of human eosinophils. J Lab Clin Med 1993; 122:567-575.
20. McCarty JM, Yee EK, Deisher TA, Harlan JM, Kaushansky K: Interleukin-4 induces endothelial vascular cell adhesion molecule-1 (VCAM-1) by an NF-kappa b-independent mechanism. FEBS Lett 1995; 372:194-198.
21. Yamazaki K, Nakadate I, Suzuki K, Sato S, Masuda T: Eosinophilia in primary biliary cirrhosis. Am J Gastroenterol 1996; 91:516-522.
22. Thompson K, Maltby J, Fallowfield J, McAulay M, Millward-Sadler H, Sheron N: Interleukin-10 experimental murine liver inflammation and fibrosis. Hepatology 1998; 28:1597-1606.
23. Louis H, Laethem J-LU, Wu W, et al: Interleukin-10 controls neutrophilic infiltration, hepatocyte proliferation, and liver fibrosis induced by carbon tetrachloride in mice. Hepatology 1998; 28:1607-1615.